Skip to search formSkip to main contentSkip to account menu

Fentora

Known as: Cephalon Brand of Fentanyl Buccal OraVescent 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

FentanylFentanyl Citrate
Fentanyl 0.8 MG Buccal Tablet [Fentora]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Effectiveness of Risk Minimization Measures for Fentanyl Buccal Tablet (FENTORA) in Canada: A Mixed-Methods Evaluation Using Surveys, Medical Chart Records and Web Surveillance
Background Fentanyl buccal tablet (FBT), a potent opioid, was approved in Canada in 2013 for breakthrough pain in opioid-tolerant… 
2015
2015
Reduction in Medication Errors: The Fentora Case Study
Fentora (fentanyl citrate) is an analgesic opioid used in the management of breakthrough pain in adult cancer patients. Numerous… 
2013
2013
High Efficacy and Significantly Shortened Neutropenia Of Dose-Dense S-HAM As Compared To Standard Double Induction: First Results Of a Prospective Randomized Trial (AML-CG 2008)
Background For curative treatment of younger patients with acute myeloid leukemia (AML) double induction with two cycles of… 
2012
2012
Phosphatized eodiscoid trilobites from the Cambrian of China
Zusammenfassung Tausende phosphatisierter Außenskelette eodiscider Trilobiten aus den Horizonten des unteren Kambriums der… 
2011
2011
FDA approves REMS for Fentora, Actiq
FDA has approved the Risk Evaluation and Mitigation Strategy (REMS) for Fentora (fentanyl buccal tablet) [C-II] and Actiq (oral… 
2009
2009
A Multicenter, Open Label Phase I/II Study of CEP701 (Lestaurtinib) in Adults with Myelofibrosis; a Report On Phase I: A Study of the Myeloproliferative Disorders Research Consortium (MPD-RC).
Abstract 754 Introduction: The identification of mutations in JAK2 in myeloproliferative neoplasms (MPN) has led to the… 
2009
2009
Specific MicroRNA Deregulated in Myleoproliferative Neoplasm Are Regulated by JAK2V617F and May Contribute to Aberrant Hematopoiesis.
Abstract 965 The myeloproliferative neoplasms (MPN), PV, ET and IMF, harbor the same gain-of-function mutation JAK2V617F at a… 
Review
2006
Review
2006
Differentiating factors between oral fast-dissolving technologies
The oral fast-dissolving systems are defined as oral drug delivery systems that dissolve or disintegrate within a few seconds to… 
2006
2006
Fentanyl Buccal Tablet in Breakthrough Pain in Opioid-Tolerant Patients with Cancer
smaller doses to reach the same peak blood concenFentanyl Buccal Tablet in trations reflects this. Breakthrough Pain in OpioidThe… 
2002
2002
Mpur prosody : an experimental-phonetic analysis with examples from two versions of the Fentora myth
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)